Sector Indices

Name Value Change %
BSE Carbonex 926.05 [19.9] [2.1]
BSE Greenex 1,517.47 [33.9] [2.2]
BSE SME IPO 288.11 [0.1] [0.1]
BSE 100 5,701.15 [123.6] [2.1]
BSE 200 2,294.82 [47.9] [2.0]
BSE 500 7,096.86 [142.1] [2.0]
BSE AUTO 10,571.31 [231.1] [2.1]
 

Hotel Leelaventure - Event Update

India Infoline Research Team / 11:36 , Aug 19, 2011

CMP Rs37, Target Rs33, Downside 11.2% 

  • In an effort to reduce leverage (FY11 net D/E at ~1.8x), Hotel Leela would sell, subject to approvals, its 183-room Kovalam property in Kerala for Rs5bn; Kovalam accounted for ~12% of FY11 revenues

  • As part of the deal, Hotel Leela would transfer the hotel to a SPV and receive shares in lieu of the transfer; subsequently, Travancore Enterprises, owned by Dr Ravi Pillai, would buy 100% of shares of the SPV from Leela for Rs5bn in cash; Hotel Leela would continue to manage the property through a management contract 

  • In FY11, Kovalam reported ARRs of Rs8,155 (+13.6% yoy) and occupancies of 67% (down 300bps yoy) with total revenues at Rs624mn

  • Hotel Leela has expressed desire to reduce debt through development of land it owns in Bangalore, Pune and Hyderabad; as part of an ‘asset light strategy’ the Kovalam hive off would generate gross proceeds equivalent to ~13% of FY11 debt of Rs38bn

  • We assume net sale proceeds to be used to repay debt in the current fiscal (company has not indicated any time line for proposed transaction); factoring the proposed hive-off, we cut FY12/13 revenue estimate by 10%/8% and retain SELL with revised 9-mth TP of Rs33 (earlier Rs37)

Financial summary
y/e 31 March (Rs m) FY10 FY11 FY12E FY13E
Revenues 4,492 5,258 5,728 7,494
yoy growth (%) (1.1) 17.1 8.9 30.8
Operating profit 1,286 1,580 1,850 2,503
OPM (%) 28.6 30.0 32.3 33.4
Pre-exceptional PAT 440 407 350 813
yoy growth (%) (71.7) (7.6) (14.0) 132.2





EPS (Rs) 1.1 1.0 0.9 2.1
P/E (x) 34.0 37.9 41.0 17.6
P/BV (x) 0.7 0.7 0.6 0.6
EV/EBITDA (x) 33.1 32.8 22.1 16.6
Debt/Equity (x) 1.4 1.8 1.1 1.1
ROE (%) 2.0 1.8 1.5 3.3
ROCE (%) 1.8 2.1 2.5 3.9
Source: Company, India Infoline Research